EUROLAB
iso-10993-12-sample-preparation-for-safety-testing
Claim Substantiation COLIPA Guidelines for Cosmetic Claim SupportEN 15886 Stability Testing of Cosmetic ProductsFDA Cosmetic Labeling Regulations TestingFDA Cosmetic Safety AssessmentFDA Cosmetic Safety Testing GuidanceFDA Guidance for Cosmetic Claim SubstantiationFDA Guidance on Cosmetic TestingFDA Voluntary Cosmetic Registration Program (VCRP) TestingISO 10993-10 Evaluation of Irritation and SensitizationISO 10993-10 Skin Irritation Testing for CosmeticsISO 10993-11 Systemic Toxicity TestingISO 10993-17 Toxicological Risk AssessmentISO 10993-18 Chemical CharacterizationISO 10993-18 Chemical Characterization of CosmeticsISO 10993-19 Assessment of Allergic Contact DermatitisISO 10993-22 Sensitization TestISO 10993-22 Sensitization TestingISO 10993-23 Assessment of UV-induced PhototoxicityISO 10993-23 Phototoxicity TestingISO 10993-5 Cytotoxicity TestingISO 11930 Challenge Testing for PreservativesISO 11930 Preservative Efficacy Testing for ClaimsISO 11930-1 Challenge Testing for Preservative EfficacyISO 11930-2 Preservative Testing for Leave-on ProductsISO 11989 Validation of Microbiological MethodsISO 15193 Packaging Testing for ClaimsISO 16128 Natural and Organic Cosmetic Ingredient VerificationISO 16128 Natural Ingredient CalculationISO 16128-2 Natural and Organic Content CalculationISO 16128-3 Methodologies for Natural Cosmetic ClaimsISO 16134 Cosmetic Safety GuidelinesISO 16134 Guidelines for Cosmetics SafetyISO 16134-2 Patch Testing for DermatologyISO 16134-3 Patch Test for Dermatological ClaimsISO 16179 Testing of Antioxidants in CosmeticsISO 16212 Detection of Yeasts and Molds in Cosmetic ProductsISO 17516 Microbial Limits for Cosmetic ClaimsISO 17516 Microbial Quality TestingISO 17516 Microbial TestingISO 21148 Anaerobic Microorganism DetectionISO 21148 Detection of Anaerobic MicroorganismsISO 21149 Aerobic Bacteria EnumerationISO 21149 Enumeration of Aerobic Bacteria for Claim SupportISO 21150 Detection of Pathogens in CosmeticsISO 21150 Microbial Contamination TestingISO 21401 Environmental Impact TestingISO 21401 Environmental Label TestingISO 22715 Cosmetic Product Labelling ComplianceISO 22716 Cosmetic Good Manufacturing Practice Compliance TestingISO 22716 GMP for Cosmetic ProductsISO 24434 Antimicrobial Effectiveness TestingISO 24441 SPF Testing for Sun Care ProductsISO 24441 UVA Protection TestingISO 24442 Microbial Spores EnumerationISO 24442 Spore EnumerationISO 24443 UVA Protection TestingISO 24444 SPF Testing ProtocolISO 24444 Sun Protection Factor (SPF) TestingISO 24475 Microbiological Raw Material TestingISO 24475 Raw Material Microbiological TestingISO 24476 Guidelines for Microbiological MethodsISO 24476 Guidelines for Microbiological TestingISO 31661 Photostability TestingISO 31661-2 UV Stability TestingOECD TG 405 In Vivo Eye Irritation TestingOECD TG 431 In Vitro Skin Corrosion TestingOECD TG 439 In Vitro Skin Irritation Testing for ClaimsOECD TG 442C In Vitro Skin SensitizationOECD TG 442D In Vitro Skin Sensitization Assay

ISO 10993-12 Sample Preparation for Safety Testing: Laboratory Testing Services

Standard-Related Information

ISO 10993-12 is a standard developed by the International Organization for Standardization (ISO) that outlines the requirements for sample preparation for safety testing of medical devices. This standard is part of the ISO 10993 series, which provides guidelines for the biological evaluation of medical devices.

The ISO 10993 series is widely recognized and adopted globally, with many countries incorporating its provisions into their national regulations and standards. The European Union, for example, has incorporated the ISO 10993 series into its Medical Device Directive (MDD), while the United States FDA has referenced it in its guidelines for medical device testing.

The standard is intended to ensure that medical devices are safe for use by providing a framework for evaluating their biological compatibility. It outlines specific requirements for sample preparation, including the selection of samples, extraction procedures, and testing parameters.

Standard Requirements and Needs

ISO 10993-12 is essential for ensuring the safety of medical devices. Medical devices can interact with the body in various ways, including through mechanical, thermal, or chemical means. As a result, it is crucial to evaluate their biological compatibility to ensure they do not cause harm to patients.

The standard requires that manufacturers conduct testing on their medical devices to demonstrate their safety and efficacy. This includes testing for toxicity, irritation, and genotoxicity, among other parameters.

Consequences of Not Performing this Test

Failure to comply with ISO 10993-12 can result in significant consequences, including:

  • Device recalls
  • Regulatory non-compliance
  • Product liability claims
  • Damage to reputation and brand image
  • Industries and Sectors that Require this Testing

    Medical device manufacturers, particularly those producing implantable devices, contact lenses, or other devices that interact with the body, must comply with ISO 10993-12. This includes companies operating in the following industries:

  • Orthopedic and bone surgery
  • Cardiology and cardiovascular systems
  • Neurosurgery and neurology
  • Ophthalmology and optometry
  • Dental and oral health
  • Risk Factors and Safety Implications

    Medical devices can pose significant risks to patients, including:

  • Infection and inflammation
  • Tissue damage and necrosis
  • Allergic reactions and hypersensitivity
  • Genotoxicity and carcinogenicity
  • Compliance with ISO 10993-12 ensures that manufacturers take a proactive approach to identifying and mitigating these risks.

    Quality Assurance and Quality Control Aspects

    ISO 10993-12 emphasizes the importance of quality assurance and control in ensuring the safety of medical devices. This includes:

  • Documenting testing procedures
  • Maintaining records of testing results
  • Conducting regular audits and inspections
  • Implementing corrective actions as necessary
  • Competitive Advantages of Having this Testing Performed

    Companies that comply with ISO 10993-12 can expect several competitive advantages, including:

  • Enhanced product safety and reliability
  • Improved reputation and brand image
  • Increased customer confidence and trust
  • Compliance with regulatory requirements
  • Reduced risk of product liability claims
  • Cost-Benefit Analysis of Performing this Test

    While the cost of complying with ISO 10993-12 may seem significant, it is essential to consider the long-term benefits. These include:

  • Reduced costs associated with device recalls and litigation
  • Improved product quality and safety
  • Enhanced brand reputation and market share
  • Compliance with regulatory requirements
  • Test Conditions and Methodology

    The following sections outline the detailed step-by-step explanation of how the test is conducted, including testing equipment and instruments used, sample preparation procedures, testing parameters and conditions, measurement and analysis methods, calibration and validation procedures, quality control measures during testing, data collection and recording procedures, and testing timeframes and duration.

    Testing Equipment and Instruments

  • Biological safety cabinets
  • Microscopes
  • Spectrophotometers
  • Chromatographs
  • Sample Preparation Procedures

  • Selecting samples for testing
  • Preparing sample extracts
  • Maintaining sample integrity
  • Testing Parameters and Conditions

  • Temperature (C)
  • Humidity (RH)
  • Pressure (kPa)
  • Measurement and Analysis Methods

  • Spectrophotometry
  • Chromatography
  • Microscopy
  • Calibration and Validation Procedures

  • Calibrating testing equipment
  • Validating testing procedures
  • Quality Control Measures During Testing

  • Maintaining records of testing results
  • Conducting regular audits and inspections
  • Data Collection and Recording Procedures

  • Documenting testing data
  • Maintaining records of testing results
  • Testing Timeframes and Duration

  • Specifying testing timelines
  • Establishing deadlines for testing completion
  • Test Reporting and Documentation

    The following sections outline how test results are documented and reported, including the report format and structure, interpretation of test results, certification and accreditation aspects, traceability and documentation requirements, reporting standards and formats, and electronic reporting systems used.

    Test Report Format and Structure

  • Introduction
  • Test methodology
  • Results
  • Discussion
  • Interpretation of Test Results

  • Evaluating testing data
  • Drawing conclusions from testing results
  • Certification and Accreditation Aspects

  • Obtaining certification for testing services
  • Maintaining accreditation with relevant regulatory bodies
  • Traceability and Documentation Requirements

  • Maintaining records of testing procedures
  • Documenting testing results
  • Reporting Standards and Formats

  • Conforming to ISO 10993-12 standards
  • Adopting standardized reporting formats
  • Electronic Reporting Systems Used

  • Utilizing software for data management and analysis
  • Adapting to emerging technologies in reporting and documentation.
  • By following this comprehensive guide, medical device manufacturers can ensure compliance with ISO 10993-12 and maintain the highest levels of product safety and quality.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers